Economic burden of rheumatoid arthritis: A systematic review

Rheumatology

Volumn 39, Issue 1, 2000, Pages 28-33

  Cooper, N J ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Costs; Economics; Review; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT;

ABSENTEEISM; ARTICLE; CONSULTATION; DATA BASE; DIAGNOSTIC TEST; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HOSPITAL CARE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0033951612     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.1.28     Document Type: Article

References (33)

1. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: replication and update. Health Care Financing Review 1985;7:61-80.
2. McIntosh E. The cost of rheumatoid arthritis. Br J Rheumatol 1996;35:781-90.
3. Sheill A, Gerard K, Donaldson C. Cost-of-illness - An aid to decision-making. Health Policy 1987;8:317-23.
4. Hodgson TA, Meiners MR. Cost-of-illness methodology-A guide to current practices and procedures. Milbank Mem Fund Q Health Society 1982;60:429-62.
5. Rice DP. Estimating the cost of illness. Am J Public Health 1967;57:424-39.
6. Hodgson TA. The state of the art of cost-of-illness estimates. Adv Health Econ Health Serv Res 1983;4:129-64.
7. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1987.
8. Rothfuss J, Mau W, Zeidler H. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: A literature review. Semin Arthritis Rheum 1997;26:771-9.
9. Department of Clinical Epidemiology and Biostatistics McMaster University Health Sciences Centre. How to read clinical journals: VII. To understand an economic evaluation (part B). Can Med Assoc J 1984;130:1542-9.
10. US Bureau of Labor Statistics. Consumer price index for all items and for medical care: 1970 1996. CPI Detailed Report, 1997.
11. Stone CE. The lifetime economic costs of rheumatoid arthritis. J Rheumatol 1984;11:819-27.
12. Gabriel SE, Crowson CS, Campion ME et al. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
13. Gabriel SE, Crowson CS, Campion ME et al. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8.
14. Yelin E. The costs of rheumatoid arthritis - absolute, incremental and marginal estimates. J Rheumatol 1996;23:47-51.
15. Clarke AE, Zowall H, Levinton C et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study. J Rheumatol 1997; 24:1051-60.
16. Scitovsky AA. Estimating the direct cost-of-illness. Milbank Mem Fund Q 1982;60:463-91.
17. Meenan RF, Yelin EH, Henke CJ et al. The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs. Arthritis Rheum 1978;21:827-33.
18. Lanes SF, Lanza LL, Radensky PW et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting-The importance of drug and surgery costs. Arthritis Rheum 1997;40: 1475-81.
19. Liang MH, Larson M, Thompson M et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
20. Lubeck DP, Spitz PW, Fries JF et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
21. Allaire SH, Prashker MJ, Meenan RF. The costs of rheumatoid arthritis. Pharmaco-Economics 1994;6: 513-22.
22. Lambert CM, Hurst NP. Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol 1995;34:774-80.
23. Pincus T. The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs 1995;50(suppl. 1):1-14.
24. Jonsson B, Rehnberg C, Borgquist L et al. Locomotion status and costs in destructive rheumatoid arthritis - a comprehensive study of 82 patients from a population of 13000. Acta Orthop Scand 1992;63:207-12.
25. Lipscomb J, Ancukiewicz M, Parmigiani G et al. Predicting the cost of illness: A comparison of alternative models applied to stroke. Med Decision Making 1998; 18:539-56.
26. van Jaarsveld CHM, Jacobs JWG, Schrijvers AJP et al. Direct cost of rheumatoid arthritis during the first six years: A cost-of-illness study. Br J Rheumatol 1998; 37:837-47.
27. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
28. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. Br Med J 1998;317:1195-200.
29. Kramer JS, Yelin EH, Epstein WV. Social and economic impacts of four musculoskeletal conditions: A study using national community-based data. Arthritis Rheum 1983; 26:901-7.
30. Drummond MF. Cost of illness - A major headache. Pharmaco-Economics 1992;2:1-4.
31. Spitz PW. The medical, personal, and social costs of rheumatoid arthritis. Nurs Clin North Am 1984;19: 575-82.
32. Wolfe F, Kleinheksel SM, Spitz PW et al. A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference. J Rheumatol 1986;13:277-84.
33. Jacobs J, Keyserling JA, Britton M, Morgan GJ Jr, Wilkenfeld J, Hutchings HC. The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program. J Clin Epidemiol 1988;41:215-23.